Skip to content
Search

Latest Stories

RSV vaccination pilot to expand to 200 pharmacies in 2025/26

CCA estimates that allowing pharmacies to deliver RSV, pneumonia, shingles, meningitis, and routine childhood vaccinations could free up 10 million GP appointments each year.

NHS to roll out RSV vaccinations across 200 pharmacies in 2025/26

NHS England aims to ensure that everyone aged 75 to 79 years old is offered RSV vaccination by 31 August 2025.

Photo credit: gettyimages

As part of its public health functions for 2025/26, NHS England plans to expand the Respiratory Syncytial Virus (RSV) immunisation programme to include up to 200 community pharmacies in targeted areas.

This follows the launch of an early adopter initiative in September 2024, where 50 community pharmacy sites in the East of England were commissioned to offer RSV vaccinations.


Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA), welcomed the expansion and urged the NHS to accelerate the rollout across more pharmacy sites.

“Pharmacies can increase access and convenience for patients so they can receive vaccines when and where they want them,” he said.

Harrison pointed out community pharmacies’ excellent track record of administering the flu and Covid-19 vaccines.

“Pharmacies have delivered over a quarter of Covid-19 vaccines to date, and increased patient access, particularly for underserved communities,” he said.

He further advocated for pharmacies to be commissioned to deliver a a wider range of NHS vaccines nationally—including RSV, pneumonia, shingles, meningitis, and routine childhood immunisations

“Taken together, we estimate that this could free up 10 million GP appointments each year,” he said.

“Alongside existing pharmaceutical services, this expansion would increase access and give patients greater choice.”

“This is especially important as vaccine uptake remains a concern, especially amongst underserved and vaccine-hesitant cohorts,” he added.

Under the updated public health functions agreement, NHS England aims to ensure that everyone aged 75 to 79 years old on 1 September 2024 is offered RSV vaccination by 31 August 2025.

It will also continue the ongoing catch-up and year-round RSV programme offer for those turning 75 years old and pregnant women (from 28 weeks).

The agreement outlines how the Secretary of State for Health and Social Care delegates responsibility for certain public health functions to NHS England. These include:

NHS England has been delegated responsibility for securing the provision of the following services:

  • National immunisation programmes
  • Population and targeted screening programmes
  • Public health services for children and adults in secure and detained settings
  • Sexual assault services
  • Child health information services

This is in addition to NHS England’s health service functions under the National Health Service Act 2006.

This agreement aims to improve population health outcomes and reduce health inequalities by continuously developing and delivering these services.

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less